Federal-Testimony Federal Testimony The American Academy of Pediatrics (AAP) provides testimony to legislative bodies regarding a variety of child health issues. The testimony documents can be found on this page. Testimony of Jerome Paulson, MD, FAAP, on the impacts of air pollition and climate change on child health, before the U.S. House of Representatives Science, Space and Technology Committee 6/4/2015 Testimony of AAP President Sandra G. Hassink, MD, FAAP before the Senate Agriculture Committee on child nutrition programs 5/7/2015 AAP testimony for the record submitted to the Senate Appropriations Committee on behalf of James M. Perrin, MD, FAAPConcerning the U.S. Government Response: Fighting Ebola and Protecting America 11/7/2014 Testimony of James. M. Perrin, MD, FAAP, before the Senate Finance Committee Health Care Subcommittee, on the Children's Health Insurance Program 9/16/2014 Testimony of Susanne E. Tanski, MD, MPH, FAAP, before the Senate Committee on Commerce, Science and Transportation on Aggressive E-Cigarette Marketing and Potential Consequences for Youth 6/18/2014 Testimony of Mark A. Gilger, MD, FAAP, before the Consumer Product Safety Commission on the child health and safety risks associated with high-powered magnet sets 10/22/2013 Testimony of Marcie Schneider, MD, FAAP, before Senate Committee on Commerce, Science, and Transportation:“Energy Drinks: Exploring Concerns About Marketing to Youth” 7/31/2013 AAP Statement for the Record: U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health Medicaid Reform Hearing 7/8/2013 Testimony of Lynda Young, MD, FAAP, before the Internal Revenue Service on its minimum essential coverage regulation 5/29/2013 Testimony of Kelly Moore, MD, FAAP, former chair, AAP Committee on Native American Child Health, before the House Appropriations Subcommittee on Interior, Environment, and Related Agencies: “Oversight Hearing- Indian Health” 3/19/2013 AAP testimony for the record, submitted to the Senate Judiciary Subcommittee on the Constitution, Civil Rights and Human Rights: “Proposals to Reduce Gun Violence: Protecting Our Communities While Respecting the Second Amendment” 2/12/2013 AAP Testimony for the Record, Drug Shortages, before the U.S. Representatives Energy and Commerce Committee Health Subcommittee 2/9/2012 Testimony of Daniel A.C. Frattarelli, MD, FAAP, AAP Committee on Drugs Chair Calls on Congress to Reauthorize Important Pediatric Drugs Laws before the House Energy & Commerce Health Subcommittee 2/1/2012 Testimony of Robert W. Block, MD, FAAP, AAP President "Breaking the Silence on Child Abuse: Protection, Prevention, Intervention, and Deterrence" before the U.S. Senate Health, Education, Labor and Pensions Committee 12/13/2011 Testimony of David Isaac Bromberg, MD, FAAP on the Health Insurance Premium Tax Credit Notice of Proposed Rulemaking before the U.S. Internal Revenue Service 11/17/2011 Testimony of Patience White, MD, MA, FAAP Senior Department Officials Considering the Composition of Essential Health Benefits before the U.S. Department of Health and Human Services 10/18/2011 Testimony of DeWayne M. Pursley, MD, MPH, FAAP on Drug Shortages before the Food and Drug Administration Center for Drug Evaluation and Research Drug Shortage Workshop 9/26/2011 Testimony of Jonathan P. Winickoff, MD, MPH, FAAPon the Regulation of Dissolvable Tobacco Products before the Food and Drug Administration Tobacco Products Scientific Advisory Committee 7/18/2011 Testimony of Jerome A. Paulson, MD, FAAP "The Clean Air Act and Public Health" before the U.S. Senate Environment and Public Works Committee 6/15/2011 Testimony of Daniel A. Frattarelli, MD, FAAP on Over-the-Counter Drug Products Containing Acetaminophen before the Food and Drug Administration Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee 5/17/2011 Testimony of Michael R. Anderson, MD, FAAP, "A Nation Prepared: Strengthening Medical and Public Health Preparedness and Response" before the U.S. Senate Committee on Health, Education, Labor and Pensions 5/17/2011 Testimony of Daniel B. Fagbuyi, MD, FAAP Taking Measure of Countermeasures Part 1 before the Subcommittee on Emergency Preparedness, Response, and Communications of the Homeland Security Committee 4/13/2011 Testimony of Andrew Racine, MD, FAAP before the Institute of Medicine Committee on Determination of Essential Health Benefits 1/14/2011 Statement of Margaret J Blythe, MD, FAAP before the Institute of Medicine's Committe on Preventive Services for Women 1/12/2011 Testimony of H. Garry Gardner, MD, FAAP on Oversight of the Consumer Product Safety Commission: Product Safety in the Holiday Season before the Senate Commerce Science & Transportation Subcommittee on Consumer Protection, Product Safety & Insurance 12/2/2010 Statement of Jonathan P. Winickoff, MD, MPH, FAAP before the Food and Drug Administration Tobacco Products Scientific Advisory Committee 11/18/2010 Testimony of Joel S. Brenner, MD, MPH, FAAP on Protecting School-Age Athletes from Sport-Related Concussion Injury before the Committee on Energy and Commerce Health Subcommittee U.S. House of Representatives 9/8/2010 Testimony of Daniel A.C. Frattarelli, MD, FAAP before the Committee on Health, Education, Labor and Pensions U.S. Senate 7/21/2010 Testimony of Judith S. Palfrey, MD, FAAP on National Commission on Fiscal Responsibility and Reform 6/30/2010 Testimony of Sandra G. Hassink, MD, MPH, FAAP on Childhood Obesity: Beginning the Dialogue on Reversing the Epidemic before the Committee on Health, Education, Labor and Pensions U.S. Senate 3/4/2010 Testimony of Sandra G. Hassink, MD, MPH, FAAP on Innovations in Addressing Childhood Obesity before the Energy and Commerce Subcommittee on Health U.S. House of Representatives 12/16/2009 Testimony of Jerome A. Paulson, MD, FAAP before the Environment and Public Works Committee U.S. Senate 12/8/2009 Testimony of David T. Tayloe, Jr., MD, FAAP on Challenges of the 2009-H1N1 Influenza and Its Potential Impact onSmall Businesses and Small Healthcare Practices before the U.S. House of Representatives Committee on Small Business 9/9/2009 Testimony of Susan Kressly, MD, FAAP before the Committee on Small Business Subcommittee on Regulations and Healthcare U.S. House of Representatives 6/24/2009 Testimony of Judith Palfrey, MD, FAAP President-Elect before the Committee on Health, Education, Labor and Pensions U.S. Senate 6/11/2009 Testimony of Marsha Raulerson, MD, FAAP before the Committee on Health, Education, Labor and Pensions U.S. Senate 5/14/2009 Testimony of Ruth A. Etzel, MD, PhD, FAAP before the Commerce, Science and Transportation Subcommittee on Consumer Protection, Product Safety, and Insurance 4/28/2009 Testimony of Joseph F. Hagan, Jr., MD, FAAP on Access to Prevention and Public Health for High-Risk Populations before the U.S. Senate Committee on Health, Education, Labor and Pensions 1/27/2009 Testimony of Mary Aitkenon Petition Requesting Ban on Sale of All-Terrain Vehicles Sold for Use of Children Under 16 Years Oldbefore the Consumer Product Safety Commission Public Meeting Pediatric Drug Testing Legislative and Regulatory History Safer Medicines for Children: The Need to Renew Pediatric Drug Testing Laws Testimony of David Rubin, MD, MSCE, FAAP on Foster Children and the Health Care System before the House Ways and Means Committee on Income Security and Family Support Hearing Additional Testimonies Advertising Disclaimer